Russell Becker
Lecturer
Contact
901 Walnut Street
10th Floor
Philadelphia, PA 19107
215-503-0174
215-923-7583 fax
Russell Becker
Lecturer
Research & Practice Interests
Health Economics and Outcomes Research
Economic Modeling
Education
MA, University of Virginia
Publications
- Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant
- Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
- Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder
- The cost offsets and cost-effectiveness associated with pegylated drugs: A review of the literature
- Effects of cohort selection on the results of cost-effectiveness analysis of disease-modifying drugs for relapsing-remitting multiple sclerosis
Teaching
Economic Modeling
Biography
Russell Becker is an independent strategic and research consultant with over 20 years of HEOR consulting experience. He founded Russell Becker Consulting in 2010 and consults with pharmaceutical, biotech, medical device, and diagnostic companies both large and small. His strategically consults with clients to develop HEOR research plans targeted to meet the requirements of client’s payer, provider, and HTA audiences. Additionally, he utilizes his broad portfolio of HEOR skills to conduct studies such as economic models, clinical trial design, observational studies, national patient surveys, cost-effectiveness analyses, and publication development.
He has a strong, recognized capability in developing various types of health economics models, including budget impact and cost-effectiveness models, from design through final application and/or publication. He has over 75 peer-reviewed publications and presentations and has experience teaching and communicating HEOR concepts to drug/device developer, payer, provider, and academic audiences. His experience includes a number of therapeutic areas such as cardiovascular, oncology, mental health, HIV/AIDS, pain management, urology, mental health and several others.
Prior to forming Russell Becker Consulting, Russell was the Director of HEOR for Dymaxium, Inc., where he led a group of project managers, analysts, programmers, and graphic artists in developing economic models and interfaces for models and other HEOR tools. Prior to joining Dymaxium, he worked as an HEOR consultant with IMS Consulting, Ovation Research Group (currently ICON), Parexel, and State and Federal Associates.
Russell earned his M.A. in Economics from the University of Virginia and a B.S. in Business with a minor in Economics from Pennsylvania State University. He also lectured in economics at George Mason University.